✦ LIBER ✦

A randomized, double-blind, placebo-controlled, Phase II study with and without enzastaurin in combination with docetaxel-based chemotherapy in patients with castration-resistant metastatic prostate cancer

✍ Scribed by Dreicer, Robert; Garcia, Jorge; Rini, Brian; Vogelzang, Nicholas; Srinivas, Sandy; Somer, Bradley; Shi, Peipei; Kania, Marek; Raghavan, Derek

Book ID: 120460469
Publisher: Springer US
Year: 2013
Tongue: English
Weight: 196 KB
Volume: 31
Category: Article
ISSN: 0167-6997
DOI: 10.1007/s10637-013-9940-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized, Double-Blind, Placebo-Contro

Randomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone With or Without Bevacizumab in Men With Metastatic Castration-Resistant Prostate Cancer: CALGB 90401

✍ Kelly, W. K.; Halabi, S.; Carducci, M.; George, D.; Mahoney, J. F.; Stadler, W. 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 190 KB

Randomized phase II study of danusertib

Randomized phase II study of danusertib in patients with metastatic castration-resistant prostate cancer after docetaxel failure

✍ Hielke J. Meulenbeld; Jean P. Bleuse; Elio M. Vinci; Eric Raymond; Giordano Vita 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB

Docetaxel and dasatinib or placebo in me

Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial

✍ Araujo, John C; Trudel, Géralyn C; Saad, Fred; Armstrong, Andrew J; Yu, Evan Y; 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 703 KB

Phase 3, randomized, placebo-controlled

Phase 3, randomized, placebo-controlled study of zibotentan (ZD4054) in patients with castration-resistant prostate cancer metastatic to bone

✍ Joel B. Nelson; Karim Fizazi; Kurt Miller; Celestia Higano; Judd W. Moul; Hideyu 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 846 KB

Aflibercept versus placebo in combinatio

Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial

✍ Tannock, Ian F; Fizazi, Karim; Ivanov, Sergey; Karlsson, Camilla Thellenberg; Fl 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 310 KB

Phase III, randomized, double-blind, pla

Phase III, randomized, double-blind, placebo-controlled study of modafinil for fatigue in patients treated with docetaxel-based chemotherapy

✍ Hovey, Elizabeth; de Souza, Paul; Marx, Gavin; Parente, Phillip; Rapke, Tal; Hil 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 580 KB